News
 

A vegetarian diet rich in nuts, vegetables, and soy has been linked to a lower risk of both ischemic and hemorrhagic stroke, new research suggests.

A new analysis shows that rates of intracerebral hemorrhage (ICH) have not fallen during recent years, as has been seen with ischemic stroke, and rates appear to be increasing in the elderly.

Neurofilament light (NfL) and microRNAs (miRNAs) can help to predict the course that multiple sclerosis (MS) will take for individuals, according to two new studies published in Neurology and Acta Neurologica Scandinavica. The markers could help to identify progressive disease and facilitate treatment decisions.

Neurologic effects can be a significant part of COVID-19, but does the SARS-CoV-2 virus directly damage the central nervous system or are the neurologic symptoms attributable to secondary mechanisms?

A new study investigate about the dose-response of daridorexant, a new dual orexin receptor antagonist, on wake after sleep onset (WASO).

On Thursday 9 June 1870, the celebrated novelist Charles Dickens died at his home at Gad's Hill Place in Kent at the age of 58 years, a day after suffering a stroke.

Despite the ever-increasing acceptance of medical cannabis and its notably common use in patients with multiple sclerosis (MS), clinicians treating those patients still may be poorly informed about risks, benefits, regulations, and proper uses, experts say.

Researchers are taking a closer look at whether the diabetes medication metformin might convey benefit in patients with both Parkinson's disease (PD) and diabetes - and are finding some positive signals.

Preclinical evidence with nilotinib, a US Food and Drug Administration (FDA)‐approved drug for leukemia, indicates improvement in Alzheimer's disease phenotypes.

The calcitonin gene-related peptide monoclonal antibody galcanezumab (Emgality, Lilly) compared favorably to placebo for reducing the number of average monthly migraine days in a new study of people with treatment-resistant migraine headaches.